T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Elevance Health
ELV
|
+$1.16B |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$1.01B |
| 4 |
Royal Caribbean
RCL
|
+$860M |
| 5 |
AET
Aetna Inc
AET
|
+$790M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.76B |
| 2 |
Biogen
BIIB
|
+$1.47B |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.26B |
| 4 |
McKesson
MCK
|
+$1.2B |
| 5 |
Sherwin-Williams
SHW
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.75% |
| 2 | Consumer Discretionary | 14.84% |
| 3 | Financials | 13.9% |
| 4 | Technology | 11.11% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTCN
1451
DELISTED
ARCELORMITTAL 6% MANDATORILTY CONV SUB NT DUE 2016 (LUX)
MTCN
| $4.31M | ﹤0.01% |
522,826
| – | – |
|
1452
BHP
BHP
$222B
| $4.29M | ﹤0.01% |
152,232
+1,345
| +0.9% | +$43.7K |
|
|
PLCM
1453
DELISTED
POLYCOM INC
PLCM
| $4.28M | ﹤0.01% |
408,524
-35,800
| -8% | -$388K |
|
1454
Tanger
SKT
$4.42B
| $4.28M | ﹤0.01% |
129,780
| – | – |
|
1455
TriNet
TNET
$3.22B
| $4.21M | ﹤0.01% |
250,600
-1,834,600
| -88% | -$37.5M |
|
1456
Antero Resources
AR
$11.3B
| $4.18M | ﹤0.01% |
197,693
-200,250
| -50% | -$5.33M |
|
1457
Nektar Therapeutics
NKTR
$2.57B
| $4.14M | ﹤0.01% |
25,213
+600
| +2% | +$106K |
|
1458
SolarEdge
SEDG
$1.98B
| $4.1M | ﹤0.01% |
+178,947
| New | +$5.01M |
|
|
TTOO
1459
DELISTED
T2 Biosystems, Inc
TTOO
| $4.1M | ﹤0.01% |
94
+1
| +1% | +$66.4K |
|
1460
Shake Shack
SHAK
$2.98B
| $4.09M | ﹤0.01% |
86,290
-500
| -0.6% | -$27.2K |
|
1461
Enerpac Tool Group
EPAC
$1.89B
| $4.06M | ﹤0.01% |
220,800
-30,100
| -12% | -$643K |
|
1462
St. Joe Company
JOE
$3.89B
| $4.04M | ﹤0.01% |
211,043
-7,066,045
| -97% | -$120M |
|
|
ALDR
1463
DELISTED
Alder Biopharmaceuticals
ALDR
| $4.02M | ﹤0.01% |
122,638
+79,638
| +185% | +$3.39M |
|
1464
Buckle
BKE
$2.31B
| $4.01M | ﹤0.01% |
108,362
-4,300
| -4% | -$181K |
|
|
JUNO
1465
DELISTED
Juno Therapeutics, Inc.
JUNO
| $3.98M | ﹤0.01% |
97,806
-294
| -0.3% | -$12.9K |
|
1466
Freshpet
FRPT
$3.5B
| $3.97M | ﹤0.01% |
378,440
-401,800
| -51% | -$5.81M |
|
1467
Copa Holdings
CPA
$6.17B
| $3.87M | ﹤0.01% |
92,400
-32,125
| -26% | -$2.03M |
|
1468
Monolithic Power Systems
MPWR
$67B
| $3.86M | ﹤0.01% |
75,400
| – | – |
|
1469
Oil States International
OIS
$526M
| $3.83M | ﹤0.01% |
146,730
+4,900
| +3% | +$145K |
|
1470
Liberty Media Series C
FWONK
$26B
| $3.83M | ﹤0.01% |
156,872
-5,989
| -4% | -$154K |
|
|
QEP
1471
DELISTED
QEP RESOURCES, INC.
QEP
| $3.79M | ﹤0.01% |
302,900
+23,780
| +9% | +$328K |
|
|
STAY
1472
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $3.76M | ﹤0.01% |
223,900
+31,900
| +17% | +$585K |
|
1473
Box
BOX
$4.66B
| $3.75M | ﹤0.01% |
+298,231
| New | +$4.44M |
|
|
WSTC
1474
DELISTED
West Corporation
WSTC
| $3.72M | ﹤0.01% |
166,000
+12,000
| +8% | +$316K |
|
1475
Corpay
CPAY
$27.9B
| $3.69M | ﹤0.01% |
26,836
+2,410
| +10% | +$370K |
|
Similar funds
T. Rowe Price Associates's Q3 2015 Portfolio in Review
As of Q3 2015, T. Rowe Price Associates held 2,618 positions worth $449B, down 7.6% from $486B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q3 2015 filing shows 86 new, 1,108 increased, 800 reduced and 108 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M. The largest sale was Baidu, an estimated $1.76B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M.
- T. Rowe Price Associates added most to Microsoft in Q3 2015, an estimated $1.57B increase.
- T. Rowe Price Associates's biggest Q3 2015 reduction was Baidu, cutting an estimated $1.76B.
- T. Rowe Price Associates fully exited HOSPIRA INC in Q3 2015, selling an estimated $988M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $449B portfolio in Q3 2015.
- T. Rowe Price Associates opened 86 new positions and closed 108 in Q3 2015.
- T. Rowe Price Associates's portfolio value fell 7.6% quarter-over-quarter to $449B.
Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.